15 January 2008
Rhabdomyolysis in sertraline intoxication: a case report
Sule Akin, Anis Aribogan, Daniel R. BrownAm J Case Rep 2008; 9:23-26 :: ID: 690775
Abstract
Background: Sertraline is a selective serotonin reuptake inhibitor used for the treatment of depression. This case report presents a patient with sertraline overdos and serotonin syndrome complicated by rhabdomyolysis.
Case Report: A 31-year-old male patient was brought to the hospital by relatives 48 hours after taking 42 tablets of sertaline HCl (Lustral, 50 mg/tablet, Pfizer) during a suicide attempt. He was generally lethargic but did have brief episodes of agitation without apparent precipitating factors. The patient was admitted to intensive care unit after laboratory evaluation indicated acute renal failure and rhabdomyolysis. Physical exam was notable for hyperreflexia and inducible clonus. Therapy included administration of cyproheptadine for serotonin syndrome and forced diuresis for renal failure by administration of crystalloids and furosemide. The patient’s neurological and biochemical profile improved and the patient was discharged on the 10[sup]th [/sup]day of admission without residual organ impairment.
Conclusions: This case is consistent with an unusual presentation of serotonin syndrome 48 hours following an overdose of sertraline.
Keywords: Sertraline, Serotonin Syndrome, rhabdomyolysis
895 6
In Press
31 May 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.940611
31 May 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939870
31 May 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.940681
31 May 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.941006
Most Viewed Current Articles
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
07 Dec 2021 : Case report
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250